The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1b/2, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naïve patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).
 
Ezra E.W. Cohen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; EMD Serono; Human Longevity, Inc; Incyte; Mavu Pharmaceutical; Merck; Nanobiotix; Pfizer
 
Lisle Nabell
No Relationships to Disclose
 
Deborah J.L. Wong
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; Genentech/Roche
Research Funding - ARMO BioSciences; AstraZeneca/MedImmune; BioMed Valley Discoveries; Bristol-Myers Squibb; Genentech/Roche; Kura Oncology; Merck Serono; Merck Sharp & Dohme; Regeneron
 
Terry A Day
No Relationships to Disclose
 
Gregory A. Daniels
Honoraria - Sanofi/Regeneron
Consulting or Advisory Role - Sanofi/Regeneron
Speakers' Bureau - Array BioPharma; Regeneron; Sanofi/Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Nektar (Inst); Viralytics (Inst)
 
Mohammed M. Milhem
Honoraria - Amgen; Blueprint Medicines; Immunocore; Trieza Therapeutics
Consulting or Advisory Role - Amgen; Blueprint Medicines; Immunocore; Trieza Therapeutics
Research Funding - Amgen (Inst); E.R. Squibb Sons, LLC (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst)
 
Sanjeev Deva
No Relationships to Disclose
 
Michael B. Jameson
Research Funding - BeiGene (Inst); Bristol-Myers Squibb (Inst); Dynavax Technologies (Inst); Lilly (Inst); Merck (Inst); Pfizer (Inst); Sabinsa Corporation (Inst)
 
Orlando Guntinas-Lichius
No Relationships to Disclose
 
Mohammed Almubarak
No Relationships to Disclose
 
Robert Matthew Strother
Research Funding - Lilly (Inst)
 
Eric D. Whitman
Consulting or Advisory Role - Bristol-Myers Squibb; Castle Biosciences; Merck Sharp & Dohme; Novartis
Speakers' Bureau - Bristol-Myers Squibb; Castle Biosciences; Merck Sharp & Dohme
Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Castle Biosciences (Inst); Dynavax Technologies (Inst); Genentech/Roche (Inst); Iovance Biotherapeutics (Inst); Merck Sharp & Dohme (Inst); Oncolys BioPharma (Inst); OncoSec (Inst); Provectus (Inst); Reata Pharmaceuticals (Inst); TRACON Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Lighted Polyhedral surgical retractor; Nerve monitoring dissection device
 
Michael Jon Chisamore
No Relationships to Disclose
 
Cynthia Chinedu Obiozor
Employment - Dynavax Technologies
Stock and Other Ownership Interests - Dynavax Technologies
Travel, Accommodations, Expenses - Dynavax Technologies
 
Teresa Bagulho
Employment - Dynavax Technologies
Stock and Other Ownership Interests - Dynavax Technologies
 
Albert Candia
Employment - Dynavax Technologies
Stock and Other Ownership Interests - Dynavax Technologies
 
Erick Gamelin
Employment - Dynavax Technologies
Stock and Other Ownership Interests - Dynavax Technologies
 
Robert Janssen
Employment - Dynavax Technologies
Leadership - Dynavax Technologies
Stock and Other Ownership Interests - Dynavax Technologies; Merck
 
Alain Patrick Algazi
Stock and Other Ownership Interests - OncoSec; Valitor
Consulting or Advisory Role - Array BioPharma; OncoSec; Valitor
Research Funding - Acerta Pharma (Inst); Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Dynavax Technologies (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); OncoSec (Inst); Oncosec (Inst); Tessa Therapeutics (Inst)
Travel, Accommodations, Expenses - OncoSec